Seymour JF, Kipps TJ, Eichhorst B, et al. MURANO Trial Establishes Feasibility of Time-Limited Venetoclax-Rituximab (VenR) Combination Therapy in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL). ASH Annual Meeting and Exposition 2018, abstract 184.
Harry Dolstra benoemd tot hoogleraar Translationele Immunohematologie
jun 2023 | Immuuntherapie, Leukemie, Lymfoom